BENDAMUSTINE相关论文
Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicente
...
Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicente
Background:Bendamustine was approved in China on May 26th,2019 by the National Medical Product Administration for the tr......
Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicente
Background::Bendamustine was approved in China on May 26th, 2019 by the National Medical Product Administration for the ......
Cephalon公司开发的注射用化疗药物benda-mustine HCl(Treanda)于2008年3月和11月二度在美国获准分别用于治疗慢性淋巴细胞白血病(......
Cephalon公司开发的注射用化疗药物benda-mustine HCl(Treanda)于2008年3月和11月二度在美国获准分别用于治疗慢性淋巴细胞白血病(......
...
,Everolimus enhances the cytotoxicity of bendamustine in multiple myeloma cells through a network of
...
依据在美国新奥尔良召开的美国血液病学会(ASH)会议上专家们披露的一项独立的Ⅲ期临床数据,Cephalon公司开发的新型化疗药物bendam......
Non-Hodgkin lymphoma (NHL)is one of the most common cancers affecting men of reproductive age.The high response rate ofb......
目的建立测定人血浆中苯达莫司汀及Y一羟基化苯达莫司汀浓度的高效液相色谱荧光检测法。方法色谱柱为AgilentC18柱（150mm×4．6mm......
Overall Survival and Health Care Costs of Medicare Patients with Previously Treated Chronic Lymphocy
Background: Bendamustine-based regimens are often used in the management of patients with chronic lymphocytic leukemia (......
Cephalon公司开发的注射用化疗药物benda-mustine HCl（Treanda）于2008年3月和11月二度在美国获准分别用于治疗慢性淋巴细胞白血病（CLL......
依据在美国新奥尔良召开的美国血液病学会（ASH）会议上专家们披露的一项独立的Ⅲ期临床数据，Cephalon公司开发的新型化疗药物bendamust......
背景：乳腺癌是人类最常见的恶性肿瘤之一，其发病率近年来呈上升趋势。在多种治疗乳腺癌的方法中，化疗仍是最为常用且效果较明显的重要......
